| Long name: |
CASP3 Antibody |
| Antigen: |
CASP3 |
| Synonim names: |
CASP3, CPP32B, SCA-1, CPP32 |
| Other names: |
Apopain, CASP-3, CPP-32, CPP-32, Caspase-3, Cysteine protease CPP32, PARP cleavage protease, Protein Yama, SCA-1, SREBP cleavage activity 1, SREBP cleavage activity 1, apopain, apoptosis-related cysteine peptidase, apoptosis-related cysteine protease, caspase 3, caspase 3, caspase-3, cysteine protease CPP32, procaspase3, protein Yama, caspase-3 preproprotein |
| Gene name: |
CASP3, CASP3 |
| Gene synonims: |
CASP-3, CASP3, CPP-32, CPP32, CPP32, CPP32B, SCA-1, SCA-1, CASP3 |
| Category: |
Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens) |
| Specificity: |
CASP3, This is an antibody designed to detect CASP3 |
| Purification method: |
Antigen Affinity method, Caprylic Acid Ammonium Sulfate Precipitation, etc, The most common purification methods used in the antibody production are Affinity Chromatography |
| Concentration: |
Enquire us for detailed information on the concentration of this antibody |
| Storage, shipping and handling: |
Avoid freeze / thaw cycles, Store at -20 degree C or -80 degree C |
| Applications: |
Immunohistochemistry (IHC), Western Blot (WB) |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
CASP3 |
| Short name: |
Anti- CASP3 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
apoptosis-related cysteine peptidase (Antibody to), Antibody to caspase 3 |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
CASP3 and IDBG-46394 and ENSG00000164305 and 836, CASP3 and IDBG-628521 and ENSBTAG00000015874 and 408016, CPP32 and CPP32B and SCA-1, Casp3 and IDBG-154306 and ENSMUSG00000031628 and 12367, apoptosis-related cysteine peptidase, cysteine-type endopeptidase activity involved in execution phase of apoptosis, nuclei, this GO :0001782 and B cell homeostasis and biological process this GO :0001836 and release of cytochrome c from mitochondria and biological process this GO :0004190 and aspartic-type endopeptidase activity and molecular function this GO :0004197 and cysteine-type endopeptidase activity and molecular function this GO :0004861 and cyclin-dependent protein serine/threonine kinase inhibitor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006309 and apoptotic DNA fragmentation and biological process this GO :0006508 and proteolysis and biological process this GO :0006915 and apoptotic process and biological process this GO :0006921 and cellular component disassembly involved in execution phase of apoptosis and biological process this GO :0006974 and cellular response to DNA damage stimulus and biological process this GO :0007507 and heart development and biological process this GO :0007605 and sensory perception of sound and biological process this GO :0008233 and peptidase activity and molecular function this GO :0008234 and cysteine-type peptidase activity and molecular function this GO :0008625 and extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :0008631 and intrinsic apoptotic signaling pathway in response to oxidative stress and biological process this GO :0008635 and activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c and biological process this GO :0009411 and response to UV and biological process this GO :0009611 and response to wounding and biological process this GO :0016485 and protein processing and biological process this GO :0022617 and extracellular matrix disassembly and biological process this GO :0030182 and neuron differentiation and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0030216 and keratinocyte differentiation and biological process this GO :0030218 and erythrocyte differentiation and biological process this GO :0030220 and platelet formation and biological process this GO :0030889 and negative regulation of B cell proliferation and biological process this GO :0034349 and glial cell apoptotic process and biological process this GO :0034612 and response to tumor necrosis factor and biological process this GO :0035329 and hippo signaling and biological process this GO :0042981 and regulation of apoptotic process and biological process this GO :0043029 and T cell homeostasis and biological process this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043281 and regulation of cysteine-type endopeptidase activity involved in apoptotic process and biological process this GO :0043525 and positive regulation of neuron apoptotic process and biological process this GO :0045165 and cell fate commitment and biological process this GO :0045736 and negative regulation of cyclin-dependent protein serine/threonine kinase activity and biological process this GO :0045786 and negative regulation of cell cycle and biological process this GO :0046007 and negative regulation of activated T cell proliferation and biological process this GO :0048011 and neurotrophin TRK receptor signaling pathway and biological process this GO :0051402 and neuron apoptotic process and biological process this GO :0071310 and cellular response to organic substance and biological process this GO :0097153 and cysteine-type endopeptidase activity involved in apoptotic process and molecular function this GO :0097190 and apoptotic signaling pathway and biological process this GO :0097192 and extrinsic apoptotic signaling pathway in absence of ligand and biological process this GO :0097193 and intrinsic apoptotic signaling pathway and biological process this GO :0097194 and execution phase of apoptosis and biological process this GO :0097200 and cysteine-type endopeptidase activity involved in execution phase of apoptosis and molecular function this GO :1902510 and regulation of apoptotic DNA fragmentation and biological process, this GO :0004190 : aspartic-type endopeptidase activity, this GO :0004190 : aspartic-type endopeptidase activity and also this GO :0004197 : cysteine-type endopeptidase activity and also this GO :0004861 : cyclin-dependent protein serine/threonine kinase inhibitor activity and also this GO :0005515 : protein binding and also this GO :0008233 : peptidase activity and also this GO :0008234 : cysteine-type peptidase activity and also this GO :0097153 : cysteine-type endopeptidase activity involved in apoptotic process and also this GO :0097200 : cysteine-type endopeptidase activity involved in execution phase of apoptosis, this GO :0004197 : cysteine-type endopeptidase activity, this GO :0004861 : cyclin-dependent protein serine/threonine kinase inhibitor activity, this GO :0005515 : protein binding, this GO :0008233 : peptidase activity, this GO :0008234 : cysteine-type peptidase activity, this GO :0097153 : cysteine-type endopeptidase activity involved in apoptotic process, this GO :0097200 : cysteine-type endopeptidase activity involved in execution phase of apoptosis, caspase 3 |
| Identity: |
1504 |
| Gene: |
CASP3 |
More about : CASP3 |
| Long gene name: |
caspase 3 |
| Synonyms gene name: |
apoptosis-related cysteine peptidase , apoptosis-related cysteine protease caspase 3, caspase 3 |
| Synonyms: |
CPP32 CPP32B Yama apopain |
| Locus: |
4q35, 1 |
| Discovery year: |
1996-07-22 |
| GenBank acession: |
BC016926 |
| Entrez gene record: |
836 |
| Pubmed identfication: |
8780721 |
| RefSeq identity: |
NM_004346 |
| Classification: |
Caspases |
| Havana BLAST/BLAT: |
OTTHUMG00000133681 |